Miyajima, Y.; Kawakami, T.
Correction: Miyajima, Y.; Kawakami, T. Treatment Selection for Patients with HER2-Negative Metastatic Gastric Cancer Expressing Claudin 18.2 and PD-L1. Cancers 2025, 17, 1120. Cancers 2025, 17, 3384.
https://doi.org/10.3390/cancers17203384
AMA Style
Miyajima Y, Kawakami T.
Correction: Miyajima, Y.; Kawakami, T. Treatment Selection for Patients with HER2-Negative Metastatic Gastric Cancer Expressing Claudin 18.2 and PD-L1. Cancers 2025, 17, 1120. Cancers. 2025; 17(20):3384.
https://doi.org/10.3390/cancers17203384
Chicago/Turabian Style
Miyajima, Yusuke, and Takeshi Kawakami.
2025. "Correction: Miyajima, Y.; Kawakami, T. Treatment Selection for Patients with HER2-Negative Metastatic Gastric Cancer Expressing Claudin 18.2 and PD-L1. Cancers 2025, 17, 1120" Cancers 17, no. 20: 3384.
https://doi.org/10.3390/cancers17203384
APA Style
Miyajima, Y., & Kawakami, T.
(2025). Correction: Miyajima, Y.; Kawakami, T. Treatment Selection for Patients with HER2-Negative Metastatic Gastric Cancer Expressing Claudin 18.2 and PD-L1. Cancers 2025, 17, 1120. Cancers, 17(20), 3384.
https://doi.org/10.3390/cancers17203384